Biotech company ONI has closed a USD75 million Series B funding round led by RCH Venture Partners and Casdin Capital.
Section 32, ARTIS Ventures, Vertical Venture Partners, Axon Ventures and private investors, including Paul Conley also participated, along with existing investors, including Oxford Science Enterprises, also participated in the round.
